Clinical trial · Observational

Collaborative Seamless Care in Oncology : Measure and Reinforce Safety and Adherence to Oral Cancer Treatment

Collaborative and Seamless Care in Oncology : a Study in Primary Care to Measure and Reinforce Safety and Adherence to Oral Cancer Treatment

NCT01370980CI-TRIAL-00118426completedClinicalTrials.gov clinicaltrialsPublishedExplore in graph →

Summary

Brief summary (as posted)

The purpose of this study is to implement a support interdisciplinary program(oncologists, pharmacists, physicians, nurses, leagues against cancer) of medication adherence to oral oncology treatments. The aim is to ensure continuity of care between professionals,effectiveness of treatment and patient safety.

Conditions

Conditions (1)

Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.

Condition (as posted)	Mapped entity	Match	Confidence
Cancer	Malignant Neoplasm	ALIAS	0.90

Interventions

Interventions (0)

Data not yet available

No intervention recorded.

Design

Arms and outcomes

Arms (1)

label
Study population
description
Adults (18 years old or more) with one of the following oral oncology treatments: letrozole, exémestane, imatinib, sunitinib, nilotinib, evérolimus, déférasirox

Primary outcomes (1)

measure
Change in Medication adherence
timeFrame
3 months, 6 months, 9 months, 12 months
description
MEMS data, completed by informations given in motivational interviewing

Secondary outcomes (4)

measure
Program implementation
timeFrame
1 year
description
Evaluating the implementation of the program in pharmacies
measure
Oncologists, nurses, pharmacists and patients satisfaction

Eligibility

Eligibility (as posted)

Sex: All
Minimum age: 18 Years

Show eligibility criteria text

Inclusion Criteria:

* 18 years and older
* Treated for a cancer with oral medication (letrozol, exemestan,imatinib, sunitinib, nilotinib, everolimus, deferasirox)
* French speaking

Exclusion Criteria:

\- None

References

Publications (0)

Data not yet available

No reference posted for this study.

Registry

Dates and enrollment

Start: Jul 1, 2010
Primary completion: Dec 1, 2011
Completion: Sep 1, 2014
First posted: Jun 10, 2011
Last update posted: Jul 17, 2026
Enrollment: 43 (actual)
Lead sponsor: Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland OTHER
Collaborators: Centre Hospitalier Universitaire Vaudois
Keywords: Medication Adherence, Patient Compliance, Patient Acceptance of Health Care, Administration, Oral, Cancer, Letrozol, Exemestan, Imatinib, Sunitinib, Nilotinib, Everolimus, Deferasirox

Data updated 22 days agoSource updated Jul 17, 2026source: clinicaltrials

Locations

Locations by country (1)

Country	Sites	Recruiting
Switzerland	1	0

Trial listing is informational. Eligibility is decided by the study team; contact information is on ClinicalTrials.gov.